OCT Vibrography for Biomechanical Properties of Tissues
A Study to Test the Potential of OCT Vibrography for Measuring Biomechanical Properties of Tissues
1 other identifier
interventional
90
1 country
1
Brief Summary
The overall goal of this study is to develop OCT Vibrography (aka OCT elastography) as a novel tool for measuring biomechanical properties of human tissues in vivo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2023
CompletedFirst Posted
Study publicly available on registry
March 8, 2023
CompletedStudy Start
First participant enrolled
August 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 28, 2026
October 23, 2025
May 1, 2025
3 years
February 26, 2023
October 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of subjects to successfully complete OCT Vibrography without serious unanticipated adverse events related to application of the device.
Frequency and severity of all treatment-related adverse events
1 year
Study Arms (4)
Healthy cornea
EXPERIMENTALOptical imaging of the cornea in healthy subjects
Healthy skin
EXPERIMENTALOptical imaging of the skin in healthy subjects
Healthy gingiva
EXPERIMENTALOptical imaging of the gingiva in healthy subjects
Keratoconus cornea
EXPERIMENTALOptical imaging of the cornea in mild and moderate keratoconus
Interventions
OCT vibrography
Eligibility Criteria
You may qualify if:
- Subjects with healthy eyes (age 18 - 75, N = 50)
You may not qualify if:
- Subjects with history of eye diseases, and previous eye surgeries.
- Subjects with diabetes, glaucoma family history
- Subjects allergic to anesthetic eyedrop, especially proparacaine
- Subjects with severe allergy
- Subjects who have difficulty biting
- Subjects who have recurrent corneal erosion
- Group 2:
- Subjects with healthy skin (age 18 - 75, N = 10)
- Subjects with open cuts/sores on the skin, skin infection, or any contagious skin condition
- Group 3:
- Subjects with healthy gingiva (age 18 - 75, N = 10)
- Subjects with open cuts/sores on the gingiva, gingiva infection, or any contagious gingiva condition
- Group 4:
- Mild or moderate keratoconus subjects (age 18 - 40, N = 20)
- Subjects with K-max above 60 diopters (Pentacam imaging) are excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Related Publications (3)
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003 May;135(5):620-7. doi: 10.1016/s0002-9394(02)02220-1.
PMID: 12719068BACKGROUNDde Sanctis U, Loiacono C, Richiardi L, Turco D, Mutani B, Grignolo FM. Sensitivity and specificity of posterior corneal elevation measured by Pentacam in discriminating keratoconus/subclinical keratoconus. Ophthalmology. 2008 Sep;115(9):1534-9. doi: 10.1016/j.ophtha.2008.02.020. Epub 2008 Apr 11.
PMID: 18405974BACKGROUNDLi X, Rabinowitz YS, Rasheed K, Yang H. Longitudinal study of the normal eyes in unilateral keratoconus patients. Ophthalmology. 2004 Mar;111(3):440-6. doi: 10.1016/j.ophtha.2003.06.020.
PMID: 15019316BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seok-Hyun Yun, PhD
Massachusetts General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Dermatology
Study Record Dates
First Submitted
February 26, 2023
First Posted
March 8, 2023
Study Start
August 19, 2023
Primary Completion (Estimated)
August 28, 2026
Study Completion (Estimated)
August 28, 2026
Last Updated
October 23, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share